Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.177.62ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.82ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.20ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.3.22ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.38.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.79.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.3.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.5.6 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.440ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.177.25ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.23.2 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.104 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.198ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
EG.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XAFENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BC.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
P.1.17.1 (Gamma)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.11ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.3.15ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.6.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.1.35ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.45ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.177.31ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.160.26ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.39.1.2 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.4.15 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.75.10ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.36.21ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BE.4.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GM.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.1.20ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.26ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.129 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XAY.2.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.7.10ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CM.8.1.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.7.5.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.3.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BN.1.2.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CH.1.1.25ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
DB.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CH.1.1.16ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CZ.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.1.18ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.1.29ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.4.1.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.47ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FK.1.2.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBC.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used